National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings, 74096 [2021-28277]

Download as PDF 74096 Federal Register / Vol. 86, No. 247 / Wednesday, December 29, 2021 / Notices When submitting comments or requesting information, please include the information collection request title for reference. Information Collection Request Title: Small Rural Hospital Improvement Program (SHIP) COVID–19 Testing and Mitigation Program Data Collection OMB No. 0906–0066—Extension. Abstract: The American Rescue Plan Act of 2021 (Pub. L. 117–2) provided one-time funding for awards that will be carried out under Section 711 of the Social Security Act (42 U.S.C. 912(b)(5)). The SHIP is requesting an extension of an information collection request. State grantees will improve health care in rural areas by using the funding to provide support to eligible SUPPLEMENTARY INFORMATION: Burden Statement: Burden in this context means the time expended by persons to generate, maintain, retain, disclose, or provide the information requested. This includes the time needed to review instructions; to develop, acquire, install, and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information; to search data sources; to complete and review the collection of information; and to transmit or otherwise disclose the information. The total annual burden hours estimated for this ICR are summarized in the table below. rural hospitals to increase COVID–19 testing efforts, expand access to testing in rural communities, and expand the range of mitigation activities. Need and Proposed Use of the Information: The terms and conditions for this program specify that, ‘‘hospitals will be required to report on the number of tests provided and categories in which the funding is spent.’’ The data will allow HRSA to ensure SHIP COVID–19 recipients are meeting the terms and conditions of their funding, while providing HRSA with information on the effectiveness of funds distributed through this program. Likely Respondents: The respondents will be hospital staff and designated Representatives, and State Office of Rural Health Staff. TOTAL ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Number of respondents per respondent 1,540 ....................................... Number of unique organizations funded through the program. 6 .............................................. Reported on a quarterly basis during the 18 month program or until the end of the public health emergency (whichever is first). .................................................. Form name SHIP COVID–19 Testing and Mitigation Data Reporting. 1,540 ....................................... HRSA specifically requests comments on (1) the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, (2) the accuracy of the estimated burden, (3) ways to enhance the quality, utility, and clarity of the information to be collected, and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2021–28268 Filed 12–28–21; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES khammond on DSKJM1Z7X2PROD with NOTICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. VerDate Sep<11>2014 20:20 Dec 28, 2021 Jkt 256001 The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The cooperative agreement applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the cooperative agreement applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Neurological Disorders and Stroke Initial Review Group; Neurological Sciences and Disorders C Study Section Translational Neural, Brain, and Pain Relief Devices. Date: February 8–9, 2022. Time: 10:00 a.m. to 2:00 p.m. Agenda: To review and evaluate cooperative agreement applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Virtual Meeting). Contact Person: Diana M. Cummings, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute of Neurological Disorders and Stroke, NIH, NSC, 6001 Executive Blvd., Suite 3208, Bethesda, MD 20892, cummingsdi@ ninds.nih.gov. PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 Average burden per response (in hours) Total responses 9,240 .25 9,240 ........................ Total burden hours 2,310 Total hours spend on responses for all funded organization over a 2-year period. 2,310 Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; NSD–C Member Conflict Special Emphasis Panel. Date: February 15, 2022. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate cooperative agreement applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Virtual Meeting). Contact Person: Diana M. Cummings, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute of Neurological Disorders and Stroke, NIH, NSC, 6001 Executive Blvd., Suite 3208, Bethesda, MD 20892, cummingsdi@ ninds.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) Dated: December 22, 2021. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–28277 Filed 12–28–21; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\29DEN1.SGM 29DEN1

Agencies

[Federal Register Volume 86, Number 247 (Wednesday, December 29, 2021)]
[Notices]
[Page 74096]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-28277]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The cooperative agreement applications and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the cooperative agreement 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Initial Review Group; Neurological Sciences and Disorders 
C Study Section Translational Neural, Brain, and Pain Relief 
Devices.
    Date: February 8-9, 2022.
    Time: 10:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate cooperative agreement 
applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
    Contact Person: Diana M. Cummings, Ph.D., Scientific Review 
Officer, Scientific Review Branch, National Institute of 
Neurological Disorders and Stroke, NIH, NSC, 6001 Executive Blvd., 
Suite 3208, Bethesda, MD 20892, [email protected].

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel; NSD-C Member Conflict Special 
Emphasis Panel.
    Date: February 15, 2022.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate cooperative agreement 
applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
    Contact Person: Diana M. Cummings, Ph.D., Scientific Review 
Officer, Scientific Review Branch, National Institute of 
Neurological Disorders and Stroke, NIH, NSC, 6001 Executive Blvd., 
Suite 3208, Bethesda, MD 20892, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

    Dated: December 22, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-28277 Filed 12-28-21; 8:45 am]
BILLING CODE 4140-01-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.